Premium
GOVERNMENT INITIATIVES IN THE DEVELOPMENT OF A PHARMACEUTICAL INDUSTRY IN AUSTRALIA
Author(s) -
Hirst Christine A.
Publication year - 1992
Publication title -
clinical and experimental pharmacology and physiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.752
H-Index - 103
eISSN - 1440-1681
pISSN - 0305-1870
DOI - 10.1111/j.1440-1681.1992.tb00398.x
Subject(s) - restructuring , pharmaceutical industry , government (linguistics) , purchasing , business , pharmaceutical benefits scheme , scheme (mathematics) , purchasing power , industrial organization , finance , marketing , economics , pharmacology , medicine , mathematical analysis , linguistics , philosophy , mathematics , medical prescription , keynesian economics
SUMMARY Government policy recognizes that the purchasing power of the government, through the Pharmaceutical Benefits Scheme, has suppressed prices and returns to the pharmaceutical industry in Australia, and that research, development and export activities have been low. The factor (f) scheme is designed to provide some pricing relief to those companies willing and able to undertake particular industry development activities. This scheme, together with the other changes implemented by the government, will result in the restructuring and development of the pharmaceutical industry in Australia.